Perkins Capital Management’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $745K | Sell |
26,100
-1,350
| -5% | -$46.1K | 0.7% | 41 |
|
|
2025
Q4 | $1.09M | Sell |
27,450
-300
| -1% | -$11K | 0.86% | 38 |
|
|
2025
Q3 | $978K | Sell |
27,750
-1,352
| -5% | -$46.6K | 0.86% | 38 |
|
|
2025
Q2 | $954K | Sell |
29,102
-798
| -3% | -$25.9K | 0.96% | 35 |
|
|
2025
Q1 | $965K | Sell |
29,900
-450
| -1% | -$16.7K | 1.02% | 31 |
|
|
2024
Q4 | $927K | Buy |
30,350
+400
| +1% | +$12.9K | 0.82% | 40 |
|
|
2024
Q3 | $840K | Sell |
29,950
-500
| -2% | -$12.3K | 0.79% | 41 |
|
|
2024
Q2 | $693K | Buy |
30,450
+2,600
| +9% | +$60K | 0.65% | 45 |
|
|
2024
Q1 | $847K | Hold |
27,850
| – | – | 0.71% | 45 |
|
|
2023
Q4 | $994K | Sell |
27,850
-1,500
| -5% | -$55.8K | 0.85% | 41 |
|
|
2023
Q3 | $1.29M | Sell |
29,350
-1,000
| -3% | -$48.8K | 1.27% | 26 |
|
|
2023
Q2 | $1.5M | Sell |
30,350
-3,000
| -9% | -$138K | 1.31% | 28 |
|
|
2023
Q1 | $1.38M | Hold |
33,350
| – | – | 1.3% | 29 |
|
|
2022
Q4 | $1.48M | Sell |
33,350
-1,000
| -3% | -$41.8K | 1.56% | 23 |
|
|
2022
Q3 | $1.34M | Hold |
34,350
| – | – | 1.5% | 25 |
|
|
2022
Q2 | $1.4M | Hold |
34,350
| – | – | 1.45% | 24 |
|
|
2022
Q1 | $2.26M | Sell |
34,350
-4,000
| -10% | -$259K | 1.85% | 17 |
|
|
2021
Q4 | $2.67M | Hold |
38,350
| – | – | 1.8% | 15 |
|
|
2021
Q3 | $2.67M | Hold |
38,350
| – | – | 1.65% | 20 |
|
|
2021
Q2 | $3.04M | Hold |
38,350
| – | – | 1.73% | 19 |
|
|
2021
Q1 | $2.51M | Sell |
38,350
-2,750
| -7% | -$169K | 1.45% | 21 |
|
|
2020
Q4 | $2.29M | Sell |
41,100
-3,250
| -7% | -$141K | 1.5% | 21 |
|
|
2020
Q3 | $1.77M | Buy |
+44,350
| New | +$1.88M | 1.63% | 21 |
|
|
2020
Q1 | $1.71M | Buy |
50,750
+2,050
| +4% | +$73.7K | 2.06% | 13 |
|
|
2019
Q4 | $1.58M | Sell |
48,700
-6,300
| -11% | -$179K | 1.42% | 23 |
|
|
2019
Q3 | $1.37M | Sell |
55,000
-5,750
| -9% | -$164K | 1.18% | 30 |
|
|
2019
Q2 | $1.81M | Sell |
60,750
-5,000
| -8% | -$146K | 1.27% | 24 |
|
|
2019
Q1 | $1.76M | Sell |
65,750
-10,000
| -13% | -$304K | 1.16% | 23 |
|
|
2018
Q4 | $2.32M | Sell |
75,750
-500
| -0.7% | -$15.6K | 1.8% | 16 |
|
|
2018
Q3 | $2.67M | Buy |
76,250
+5,000
| +7% | +$158K | 1.6% | 14 |
|
|
2018
Q2 | $1.93M | Sell |
71,250
-500
| -0.7% | -$11.8K | 1.38% | 18 |
|
|
2018
Q1 | $1.47M | Sell |
71,750
-16,800
| -19% | -$303K | 1.33% | 17 |
|
|
2017
Q4 | $1.61M | Sell |
88,550
-4,400
| -5% | -$87.1K | 1.55% | 16 |
|
|
2017
Q3 | $2.08M | Sell |
92,950
-42,418
| -31% | -$959K | 2.18% | 10 |
|
|
2017
Q2 | $3.28M | Sell |
135,368
-1,849
| -1% | -$39.3K | 3.64% | 4 |
|
|
2017
Q1 | $2.63M | Buy |
137,217
+9,467
| +7% | +$166K | 2.71% | 8 |
|
|
2016
Q4 | $2.5M | Buy |
127,750
+6,050
| +5% | +$110K | 2.74% | 6 |
|
|
2016
Q3 | $1.93M | Buy |
121,700
+36,600
| +43% | +$563K | 1.92% | 9 |
|
|
2016
Q2 | $1.2M | Buy |
85,100
+900
| +1% | +$13.7K | 1.38% | 19 |
|
|
2016
Q1 | $1.42M | Sell |
84,200
-50
| -0.1% | -$880 | 1.77% | 12 |
|
|
2015
Q4 | $1.89M | Buy |
84,250
+250
| +0.3% | +$5.15K | 2.03% | 10 |
|
|
2015
Q3 | $1.84M | Hold |
84,000
| – | – | 2.05% | 11 |
|
|
2015
Q2 | $2.07M | Hold |
84,000
| – | – | 1.82% | 11 |
|
|
2015
Q1 | $1.72M | Sell |
84,000
-250
| -0.3% | -$4.84K | 1.44% | 15 |
|
|
2014
Q4 | $1.68M | Sell |
84,250
-500
| -0.6% | -$8.58K | 1.44% | 15 |
|
|
2014
Q3 | $1.25M | Sell |
84,750
-45,900
| -35% | -$731K | 1.05% | 29 |
|
|
2014
Q2 | $2.4M | Sell |
130,650
-850
| -0.6% | -$14.1K | 1.69% | 13 |
|
|
2014
Q1 | $2.47M | Sell |
131,500
-60,335
| -31% | -$1.24M | 1.74% | 14 |
|
|
2013
Q4 | $3.58M | Buy |
191,835
+41,635
| +28% | +$605K | 2.42% | 7 |
|
|
2013
Q3 | $1.65M | Buy |
150,200
+37,900
| +34% | +$374K | 1.19% | 30 |
|
|
2013
Q2 | $1.07M | Buy |
+112,300
| New | +$978K | 0.85% | 41 |
|
Other funds holding ATRC
HRCM
VPM
VCM
NAMI
Perkins Capital Management's ATRC Position: Q1 2026 in Review
Perkins Capital Management reduced its AtriCure (ATRC) stake by 4.9% in Q1 2026, selling an estimated $46.1K and leaving 26,100 shares worth $745K. The position accounts for 0.7% of the portfolio, ranked #41.
Perkins Capital Management first reported a position in ATRC in Q2 2013 and has held it in 51 quarters since. The position peaked at $3.58M in Q4 2013. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.
- Perkins Capital Management held 26,100 shares of AtriCure worth $745K as of Q1 2026.
- Perkins Capital Management sold 1,350 AtriCure shares in Q1 2026, an estimated $46.1K.
- AtriCure made up 0.7% of Perkins Capital Management's portfolio in Q1 2026, its #41 holding.
- Perkins Capital Management first reported a position in AtriCure in Q2 2013 and has held it in 51 quarters since.
- Perkins Capital Management's AtriCure position peaked at $3.58M in Q4 2013.
- 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.
Based on Perkins Capital Management's 13F filing for Q1 2026, filed 23 Apr 2026.